Regarding pregnancy, which statement is true?  

Which of the following choices is true?  

Which pharmacologic effects of the opioid analgesics do patients develop tolerance? CHOOSE ALL CORRECT ANSWERS

Several FDA (US Food and drug Administration) approved opioid drugs are now available with abuse deterrent mechanisms included in the table/capsule.  These mechanisms include which of the following?

A 70-year-old man with chronic kidney disease (eGFR 45 mL/min/1.73 m²) and stage 1 hypertension (138/88 mm Hg) is evaluated. He has no diabetes or history of heart failure. What is the most appropriate initial pharmacotherapy?

You are seeing a 56-year-old Black male without any history of cardiovascular disease or diabetes. His LDL cholesterol level is 108 mg/dL, and his 10-year ASCVD risk is calculated to be 5.5%. He is currently on no medications.  His Coronary Artery Calcium score at this time is zero.   Select the appropriate intensity of statin therapy indicated for this patient.  

You diagnose GH with Stage 1 hypertension and initiate him on a blood pressure lowering medication.   How often after starting medication should the effectiveness of his antihypertensive pharmacotherapy be reassessed until he reaches his treatment goal?

A 66-year-old man with a history of myocardial infarction 6 months ago, hypertension, and symptomatic peripheral arterial disease presents for follow-up. His current medications include aspirin, metoprolol, and rosuvastatin 40 mg daily. Laboratory studies show LDL-C of 60 mg/dL. He reports no adverse effects from his medications. Which of the following is the most appropriate next step in managing his lipid profile?

Which of the following is recommended to be used to estimate 10-year CVD risk to help guide hypertension treatment?

A 45-year-old male presents with a 2-year history of type 2 diabetes, hypertension, and dyslipidemia.  He has been treated with metformin 850 mg twice daily for the past 15 months, enalapril 10 mg daily and atorvastatin 40 mg once daily. Laboratory data at this visit: A1C 7.8%, blood pressure 130/80 mmHg, LDL 85 mg/dL, triglycerides 175 mg/dL, and HDL 35 mg/dL.   His 10-year ASCVD risk is 15% and his eGFR is 50 mL/min/1.73m2.  You decide that dual therapy is appropriate  for management of his type 2 diabetes.  The best agent to add to his metformin is: